Furthermore, microvesicles generated by monocytes treated with uremic toxins induce early senescence and an increase in osteogenic markers (BMP2 and miRNA-223-3p) in VSMC, which could promote vascular damage in CKD. Here, BMP2 is linked to chronic kidney disease.